(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1315628 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MBNL2 mRNA CTD PMID:22079256 1,2-dichloroethane decreases expression ISO RGD:1315629 6480464 ethylene dichloride results in decreased expression of MBNL2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1315629 6480464 1, 2-Dimethylhydrazine results in decreased expression of MBNL2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1315629 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MBNL2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression ISO RGD:1315628 6480464 Ethinyl Estradiol results in decreased expression of MBNL2 mRNA CTD PMID:18936297 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of MBNL2 mRNA CTD PMID:17108234 17alpha-ethynylestradiol multiple interactions ISO RGD:1315629 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MBNL2 mRNA CTD PMID:17942748 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1315628 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1315629 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MBNL2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MBNL2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1315629 6480464 Tetrachlorodibenzodioxin results in decreased expression of MBNL2 mRNA CTD PMID:25270620 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1315629 6480464 Tetrachlorodibenzodioxin affects the expression of MBNL2 mRNA CTD PMID:21570461 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-methylcholine affects expression ISO RGD:1315628 6480464 beta-methylcholine affects the expression of MBNL2 mRNA CTD PMID:21179406 4,4'-sulfonyldiphenol increases expression ISO RGD:1315629 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MBNL2 mRNA CTD PMID:30951980 aflatoxin B1 decreases expression ISO RGD:1315629 6480464 Aflatoxin B1 results in decreased expression of MBNL2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1315628 6480464 Aflatoxin B1 results in decreased methylation of MBNL2 gene CTD PMID:27153756 aldrin decreases expression ISO RGD:1315629 6480464 Aldrin results in decreased expression of MBNL2 mRNA CTD PMID:18579281 all-trans-retinoic acid increases expression ISO RGD:1315628 6480464 Tretinoin results in increased expression of MBNL2 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of MBNL2 mRNA CTD PMID:20488242 antirheumatic drug increases expression ISO RGD:1315628 6480464 Antirheumatic Agents results in increased expression of MBNL2 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:1315629 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of MBNL2 mRNA CTD PMID:23650126 , PMID:25270620 arsane increases methylation ISO RGD:1315628 6480464 Arsenic results in increased methylation of MBNL2 gene CTD PMID:31135185 arsane multiple interactions ISO RGD:1315628 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MBNL2 mRNA CTD PMID:32525701 arsenic atom increases methylation ISO RGD:1315628 6480464 Arsenic results in increased methylation of MBNL2 gene CTD PMID:31135185 arsenic atom multiple interactions ISO RGD:1315628 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MBNL2 mRNA CTD PMID:32525701 arsenous acid increases expression ISO RGD:1315628 6480464 Arsenic Trioxide results in increased expression of MBNL2 mRNA CTD PMID:22521957 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of MBNL2 gene CTD PMID:28931070 benzo[a]pyrene decreases expression ISO RGD:1315628 6480464 Benzo(a)pyrene results in decreased expression of MBNL2 mRNA CTD PMID:20064835 benzo[a]pyrene affects methylation ISO RGD:1315628 6480464 Benzo(a)pyrene affects the methylation of MBNL2 5' UTR, Benzo(a)pyrene affects the methylation of MBNL2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1315628 6480464 Benzo(a)pyrene results in increased expression of MBNL2 mRNA CTD PMID:26238291 benzo[a]pyrene increases expression ISO RGD:1315629 6480464 Benzo(a)pyrene results in increased expression of MBNL2 mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1315628 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MBNL2 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:1315629 6480464 bisphenol A results in increased methylation of MBNL2 promoter CTD PMID:27312807 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of MBNL2 gene CTD PMID:28505145 bisphenol A increases expression ISO RGD:1315629 6480464 bisphenol A results in increased expression of MBNL2 mRNA CTD PMID:21932408 , PMID:25594700 bisphenol F increases expression ISO RGD:1315629 6480464 bisphenol F results in increased expression of MBNL2 mRNA CTD PMID:30951980 captan increases expression ISO RGD:1315629 6480464 Captan results in increased expression of MBNL2 mRNA CTD PMID:31558096 ciguatoxin CTX1B affects expression ISO RGD:1315629 6480464 Ciguatoxins affects the expression of MBNL2 mRNA CTD PMID:18353800 clorgyline increases expression ISO RGD:1315628 6480464 Clorgyline results in increased expression of MBNL2 mRNA CTD PMID:19691856 copper atom increases expression EXP 6480464 Copper results in increased expression of MBNL2 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of MBNL2 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:1315628 6480464 Copper Sulfate results in increased expression of MBNL2 mRNA CTD PMID:19549813 crocidolite asbestos affects expression ISO RGD:1315628 6480464 Asbestos, Crocidolite affects the expression of MBNL2 mRNA CTD PMID:25757056 cyclosporin A decreases expression ISO RGD:1315629 6480464 Cyclosporine results in decreased expression of MBNL2 mRNA CTD PMID:19770486 cyclosporin A increases expression ISO RGD:1315628 6480464 Cyclosporine results in increased expression of MBNL2 mRNA CTD PMID:20106945 more ... cyproconazole increases expression ISO RGD:1315629 6480464 cyproconazole results in increased expression of MBNL2 mRNA CTD PMID:22334560 diarsenic trioxide increases expression ISO RGD:1315628 6480464 Arsenic Trioxide results in increased expression of MBNL2 mRNA CTD PMID:22521957 dibutyl phthalate increases expression ISO RGD:1315629 6480464 Dibutyl Phthalate results in increased expression of MBNL2 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of MBNL2 mRNA CTD PMID:21266533 dioxygen increases expression ISO RGD:1315628 6480464 Oxygen deficiency results in increased expression of MBNL2 mRNA CTD PMID:20042640 dorsomorphin multiple interactions ISO RGD:1315628 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1315628 6480464 Doxorubicin results in decreased expression of MBNL2 mRNA CTD PMID:29803840 entinostat decreases expression ISO RGD:1315628 6480464 entinostat results in decreased expression of MBNL2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1315628 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MBNL2 mRNA CTD PMID:27188386 epoxiconazole increases expression ISO RGD:1315629 6480464 epoxiconazole results in increased expression of MBNL2 mRNA CTD PMID:22334560 ethanol affects expression ISO RGD:1315629 6480464 Ethanol affects the expression of MBNL2 mRNA CTD PMID:30319688 ethanol affects splicing ISO RGD:1315629 6480464 Ethanol affects the splicing of MBNL2 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1315628 6480464 Ethyl Methanesulfonate results in increased expression of MBNL2 mRNA CTD PMID:23649840 folic acid multiple interactions ISO RGD:1315629 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MBNL2 mRNA CTD PMID:22206623 folic acid decreases expression ISO RGD:1315629 6480464 Folic Acid results in decreased expression of MBNL2 mRNA CTD PMID:25629700 geldanamycin increases expression ISO RGD:1315628 6480464 geldanamycin results in increased expression of MBNL2 mRNA CTD PMID:26705709 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of MBNL2 mRNA CTD PMID:24136188 gold atom decreases expression ISO RGD:1315628 6480464 Gold results in decreased expression of MBNL2 mRNA CTD PMID:25523186 gold(0) decreases expression ISO RGD:1315628 6480464 Gold results in decreased expression of MBNL2 mRNA CTD PMID:25523186 leflunomide increases expression ISO RGD:1315628 6480464 leflunomide results in increased expression of MBNL2 mRNA CTD PMID:28988120 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of MBNL2 mRNA CTD PMID:30467583 methyl methanesulfonate increases expression ISO RGD:1315628 6480464 Methyl Methanesulfonate results in increased expression of MBNL2 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1315628 6480464 methylmercuric chloride results in decreased expression of MBNL2 mRNA CTD PMID:28001369 methylmercury chloride increases expression ISO RGD:1315628 6480464 methylmercuric chloride results in increased expression of MBNL2 mRNA CTD PMID:28001369 methylseleninic acid increases expression ISO RGD:1315628 6480464 methylselenic acid results in increased expression of MBNL2 mRNA CTD PMID:18548127 miconazole decreases expression ISO RGD:1315629 6480464 Miconazole results in decreased expression of MBNL2 mRNA CTD PMID:27462272 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO RGD:1315628 6480464 N more ... CTD PMID:12756304 nickel dichloride increases expression ISO RGD:1315628 6480464 nickel chloride results in increased expression of MBNL2 mRNA CTD PMID:17312168 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MBNL2 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1315629 6480464 Acetaminophen affects the expression of MBNL2 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1315628 6480464 Acetaminophen results in decreased expression of MBNL2 mRNA CTD PMID:21420995 perfluorononanoic acid increases expression ISO RGD:1315628 6480464 perfluorononanoic acid results in increased expression of MBNL2 mRNA CTD PMID:32588087 phenobarbital affects expression ISO RGD:1315629 6480464 Phenobarbital affects the expression of MBNL2 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1315628 6480464 Phenylmercuric Acetate results in increased expression of MBNL2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1315628 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBNL2 mRNA CTD PMID:27188386 potassium chromate multiple interactions ISO RGD:1315628 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MBNL2 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1315628 6480464 potassium chromate(VI) results in decreased expression of MBNL2 mRNA CTD PMID:22079256 propiconazole increases expression ISO RGD:1315629 6480464 propiconazole results in increased expression of MBNL2 mRNA CTD PMID:21278054 , PMID:22334560 quercetin decreases expression ISO RGD:1315628 6480464 Quercetin results in decreased expression of MBNL2 mRNA CTD PMID:21632981 raloxifene multiple interactions ISO RGD:1315628 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of MBNL2 mRNA CTD PMID:19059307 rotenone decreases expression ISO RGD:1315628 6480464 Rotenone results in decreased expression of MBNL2 mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO RGD:1315628 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom decreases expression ISO RGD:1315629 6480464 Silver results in decreased expression of MBNL2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1315629 6480464 Silver results in decreased expression of MBNL2 mRNA CTD PMID:27131904 sirolimus multiple interactions ISO RGD:1315628 6480464 Sirolimus inhibits the reaction [TP73 protein results in increased expression of MBNL2 mRNA] CTD PMID:21245298 sodium arsenate multiple interactions ISO RGD:1315628 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MBNL2 mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO RGD:1315628 6480464 sodium arsenite results in decreased expression of MBNL2 mRNA CTD PMID:28595984 sodium dichromate increases expression ISO RGD:1315629 6480464 sodium bichromate results in increased expression of MBNL2 mRNA CTD PMID:31558096 succimer multiple interactions ISO RGD:1315629 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MBNL2 mRNA CTD PMID:26378955 sunitinib increases expression ISO RGD:1315628 6480464 Sunitinib results in increased expression of MBNL2 mRNA CTD PMID:31533062 tacrolimus hydrate decreases expression ISO RGD:1315629 6480464 Tacrolimus results in decreased expression of MBNL2 mRNA CTD PMID:25270620 tamoxifen multiple interactions ISO RGD:1315628 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of MBNL2 mRNA CTD PMID:19059307 tert-butyl hydroperoxide decreases expression ISO RGD:1315628 6480464 tert-Butylhydroperoxide results in decreased expression of MBNL2 mRNA CTD PMID:15336504 testosterone enanthate affects expression ISO RGD:1315628 6480464 testosterone enanthate affects the expression of MBNL2 mRNA CTD PMID:17440010 tetrachloromethane increases expression ISO RGD:1315629 6480464 Carbon Tetrachloride results in increased expression of MBNL2 mRNA CTD PMID:27339419 , PMID:31919559 thapsigargin increases expression ISO RGD:1315628 6480464 Thapsigargin results in increased expression of MBNL2 mRNA CTD PMID:29453283 thimerosal decreases expression ISO RGD:1315628 6480464 Thimerosal results in decreased expression of MBNL2 mRNA CTD PMID:27188386 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MBNL2 mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:1315628 6480464 torcetrapib results in increased expression of MBNL2 mRNA CTD PMID:23228038 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of MBNL2 gene CTD PMID:27618143 trichostatin A increases expression ISO RGD:1315628 6480464 trichostatin A results in increased expression of MBNL2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A affects expression ISO RGD:1315628 6480464 trichostatin A affects the expression of MBNL2 mRNA CTD PMID:28542535 trichostatin A multiple interactions ISO RGD:1315628 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBNL2 mRNA CTD PMID:27188386 troglitazone increases expression ISO RGD:1315629 6480464 troglitazone results in increased expression of MBNL2 mRNA CTD PMID:28973697 urethane increases expression ISO RGD:1315628 6480464 Urethane results in increased expression of MBNL2 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:1315628 6480464 Valproic Acid results in increased expression of MBNL2 mRNA CTD PMID:24935251 , PMID:26272509 valproic acid decreases expression ISO RGD:1315628 6480464 Valproic Acid results in decreased expression of MBNL2 mRNA CTD PMID:28001369 valproic acid multiple interactions ISO RGD:1315628 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBNL2 mRNA CTD PMID:27188386 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MBNL2 mRNA CTD PMID:19015723 zinc sulfate decreases expression ISO RGD:1315628 6480464 Zinc Sulfate results in decreased expression of MBNL2 mRNA CTD PMID:12756304 
Gene Ontology Annotations
